It has been shown that RYBP inhibits the progression and metastasis of lung cancer by suppressing EGFR signaling and EMT [19], and high levels of PKP1 are important to maintain a high expression of vimentin, which is a key regulator of EMT and metastasis [46]. Here, RYBP is linked to lung carcinoma.